Financials
- Market Capitalization 255.18 M
- Employee 389
- Founded 1999
- CEO N/A
- Website www.standardbio.com
- Headquarter Delaware, United States
- FIGI BBG000S8WQB6
- Industry 診断・研究
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-6.4
売上高対価格比率
5.73
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3326 | MYGN Myriad Genetics, Inc. - Common Stock | 3.09 USD | -2.83% | -3.74% | -42.03% | -62.64% | 295.56 M USD | ||
| 3333 | BDSX Biodesix, Inc. - Common Stock | 27.84 USD | -2.25% | +9.13% | +31.07% | +122.54% | 293.74 M USD | ||
| 3554 | STIM Neuronetics, Inc. - Common Stock | 2.97 USD | +0.34% | -3.26% | +59.68% | -14.16% | 226.31 M USD | ||
| 3679 | XGN Exagen Inc. - Common Stock | 7.38 USD | -1.86% | -6.46% | +65.47% | -24.39% | 178.78 M USD |